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Introduction 
The study of protein translocation across the bacterial 
cytoplasmic membrane is a rapidly advancing area of 
current biological research. In Escherichia coli, proteins 
are exported to the periplasmic space and outer mem- 
brane. These proteins are synthesized in the cytosol as 
precursors, mostly with a cleavable signal sequence. 
The pioneering work of Beckwith, Silhavy, Ito, and co- 
workers [for reviews, see refs. 17, 63, and 132; for a 
chronological perspective of important findings in bac- 
terial protein export, see ref. 162] has established that the 
targeting and translocation of precursor proteins across 
the cytoplasmic membrane requires the products of at 
least six sec-genes. These genes, secA, secB, secD, secE, 
secF, and secY, encode interacting core-components of a 
complex translocation apparatus that consists of soluble, 
peripheral and membrane integrated proteins (Table, and 
Fig. 1) [For review, see 162]. Homologous genes have 
been found in many other Bacteria nd even in Archaea, 
indicating that this pathway is widely distributed. In ad- 
dition, several other factors have been found that may 
contribute to the translocation reaction. Sec proteins 
have been purified to homogeneity and reconstituted into 
liposomes [25]. These proteoliposomes translocate pre- 
cursor proteins across the lipid bilayer in an energy- 
dependent manner. The mechanism of protein translo- 
cation across the bacterial cytoplasmic membrane and 
the membrane of the endoplasmic reticulum (ER) or thy- 
lakoid of eukaryotic ells may share many features in 
common [52, 57, 75]. It has been known for some time 
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that signal sequences of these systems are functionally 
interchangeable. It has just recently become apparent 
that these systems also share homologous components, 
suggesting that protein translocation may occur via a 
common mechanism. In this review, I will concentrate 
on the biochemical role of the individual components of
this general protein export pathway, and not discuss Sec- 
independent translocation or the alternative and dedi- 
cated protein translocation pathways that also exist in 
Bacteria [121, 153]. 
Protein Translocation Is Mediated by a 
Muitisubunit Translocase Complex 
In E. coli, precursor proteins are first recognized in the 
cytosol and maintained in a translocation-competent 
state by the SecB protein. SecB promotes the interaction 
of precursor proteins with the SecA protein. SecA is an 
ATPase, and at the membrane surface it interacts with 
acidic phospholipids and a multisubunit integral mem- 
brane protein complex consisting of the SecY, SecE and 
Band 1 or SecG 1 polypeptides. Together these proteins 
form a complex termed the translocase. Translocase 
mediates the ATP- and Ap-dependent translocation of 
precursor proteins across the membrane. SecD, and 
SecF are needed for the late stages of translocation. Dur- 
ing translocation, the signal peptide is removed from the 
precursor protein by the membrane-bound signal pepti- 
dase SP-I or SP-II. The latter signal peptidase is specific 
1 For simplicity, I use the term SecY/E complex to indicate the integral 
membrane protein complex of SecY, SecE and "band 1." The latter is 
identical to component "P12" [39a]. See section on integral membrane 
components. 
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Table 1. Components implicated in protein export in E. coli 
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Component Function Molecular Location b Copies Eukaryotic 
mass a (kD) per cell homologue 
Translocase 
SecA Translocation-ATPase, SecB- 
precursor protein receptor, 
molecular chaperone 102 (2) im, c 2500-5000 c - -  
SecY Channel subunit, signal se- 
quence receptor 49 im 300-600 c'd SEC6 loop 
SecE Channel subunit, stabilizes SecY 14 im 200-400 c'd SEC61yp 
SecG Band 1 ----Copurifies/as sociates 
with SecY/E 14.7 e im ? SEC6113p? 
P12--Stimulates in vitro translo- 
cation 11.4 im ? 
Others 
SecB Molecular chaperone, protein 
targeting to SecA 14 (4-5) c ? 
SecD Protein release in periplasm, 
maintenance Ap 67 im 450-900c/7-30 d 
SecF Maintenance Ap 35 im 30-60c/7-30 d 
Signal recognition particle 
Ffs 4.5 S RNA, SRP subunit 
Ffh Signal sequence binding factor, 
GTPase, SRP subunit 
FtsY Subunit SRP receptor, GTPase 
c ? 7 SL RNA 
48 c ? SRP54 
48 im, c ? SRPc~ 
Signal peptidases 
LepB Signal peptidase I 36 im ? SEC1 lp 
LspA Signal peptidase II 18 im ? - -  
a Subunit composition i dicated in parentheses; him, inner membrane; cy, cytosol; p, periplasm; Cfrom Ref. [99] and dRef. [118]; eSDS-PAGE 
estimate; --/?, unknown. 
for lipoproteins. Other proteins are required for proper 
folding, assembly in multisubunit s ructures and/or co- 
valent modification with lipids. This highly efficient 
system handles protein translocation rates of up to 1,000 
amino acid residues per sec, allowing an E. coli to double 
every 20 min. 
SecB Is A CHAPERONE SPECIFIC TO PROTEIN EXPORT 
In E. coli, precursor protein synthesis and membrane 
translocation are not strictly coupled [123]. This led to 
the view that translocation of proteins across the cyto- 
plasmic membrane is not driven by the ribosome's poly- 
peptide chain elongation machinery per se. Precursor 
protein can be translocated as a completed polypeptide 
chain [123]. In the cytosol, molecular chaperones pre- 
vent the stable folding of precursor proteins. SecB is a 
homotetrameric chaperone protein with a specific func- 
tion in protein translocation [32, 78, 161]. It forms a 
stoichiometric complex with precursor proteins [87], but 
does not catalyze folding or unfolding nor does it interact 
with ATP. SecB, however, stabilizes the unfolded pro- 
tein in a soluble state, and hence may retard folding 
sufficiently to bring about a productive interaction of the 
precursor protein with other Sec proteins in order to be- 
come translocated. This view is supported by in vitro 
studies that demonstrate that precursor proteins can 
spontaneously form a translocation-competent sta e 
when diluted into solution from denaturant, while they 
lose their translocation competence during prolonged in- 
cubation in the absence of SecB [21, 32, 87, 91]. SecB 
retards the folding of the precursor of maltose binding 
protein (pre-MBP) [126], and prevents the formation of 
insoluble aggregates of the rapidly folding precursors of 
the outer membrane proteins OmpA [86] and PhoE [21]. 
SecB associates with the mature domain of precursor 
proteins [ 126], but the specificity of this binding reaction 
has remained elusive. Some precursor proteins, such as 
pre-ribose binding protein (pre-RBP) do not require 
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Fig. 1. Schematic overview of the Sec 
components involved in the general protein export 
pathway in E. coli. 
SecB for export, but single point mutations that presum- 
ably affect he folding of pre-RBP, suffice to render its 
translocation SecB-dependent. I  has been suggested 
that SecB recognizes the polypeptide backbone, and that 
it binds preferentially atsites exhibiting 13-conformation. 
OmpA and PhoE bear a high amount of I]-structure both 
in their final conformations and in the SecB bound pre- 
cursor forms [21, 86]. SecB will also bind with low 
affinity to short peptides carrying a net positive charge 
(i.e., arginine and lysine residues) [124], including syn- 
thetic signal peptides (A.J.M. Driessen, unpublished). 
It has been suggested that the signal sequence domain of 
precursor proteins is essential for recognition by SecB 
[157]. Other studies uggest that the signal sequence fa- 
cilitates binding of the precursor protein to SecB by re- 
tarding the folding of the mature domain [126]. In vitro 
data indicate that SecB will bind to a variety of unfolded 
proteins, but not to native proteins. The kinetic partition 
model proposes that SecB preferentially associates with 
slow folding proteins, while rapidly folding proteins are 
precluded from binding [55]. This model seems appro- 
priate for the folding in the test tube, but it may not 
explain the high selectivity of SecB in vivo where it 
associates preferentially with polysome-bound ascent 
polypeptide chains of pre-MBP and a number of outer 
membrane proteins [79], while SecB is also needed for 
cotranslation translocation [80]. 
SecB is essential only in rapidly growing cells, sug- 
gesting that its function is required when the demand on 
the export pathway is high. The specific function of 
SecB in protein export may relate to its binding affinity 
for SecA that allows a rapid and specific targeting of 
bound precursor proteins to the membrane surface [31, 
56]. SecB binds to SecA in solution, thereby promoting 
the binding of precursor proteins to SecA [56, A.J.M. 
Driessen, unpublished]. SecB may facilitate afunctional 
interaction of the precursor protein with SecA by pre- 
senting the signal sequence in a proper conformation. 
This defines the role of SecB as a factor that binds to 
nascent polypeptide chains when they emerge from the 
ribosome, stabilizes the completely synthesized precur- 
sors in a translocation-competent co formation and di- 
rects them to the SecA subunit of the translocase in the 
cytosol. 
Various other soluble chaperone proteins are in- 
volved in stabilizing newly synthesized precursor pro- 
teins. Induction of the heat-shock response substitutes 
for a defect in SecB function. This appears to be due to, 
as yet unidentified, heat-shock proteins other than 
GroEL/ES and DnaK [7]. These latter chaperones can- 
not replace SecB, and are involved in specific functions 
only [84, 85, 113]. 
SIGNAL RECOGNITION PARTICLE: A COMPONENT OF A 
COTRANSLATION BRANCH OF THE Sec PATHWAY. 9 
Signal recognition particle (SRP) is essential for target- 
ing of nascent chains to the ER membrane of Eukaryotes 
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[127]. It consists of one RNA (7 SL RNA) and six pro- 
tein subunits. The N-terminal domain of the 54K subunit 
of SRP (SRP54) contains a GTP binding site, whereas 
the C-terminal domain binds signal sequences and SRP 
RNA. Binding of SRP to the signal sequence as it 
emerges from the ribosome creates a cytosolic targeting 
complex containing the nascent polypeptide chain, the 
translating ribosome, and SRP. This complex is targeted 
to the ER membrane and binds to the SRP receptor, a
protein composed of two subunits, SRtx and SR[3, both 
also containing a GTP-binding domain. SRP54 is stabi- 
lized by signal sequences, and binding of SRP to the SRP 
receptor activates SRP54 for GTP hydrolysis [102]. SRP 
then dissociates from both the signal sequence [107, 131] 
and the ribosome [51], that bind to SEC61p. SRP is 
released from the SRP receptor and recycled in the cy- 
tosol. The identification of a SRP homologue in E. coli, 
several other Bacteria and Archaea, suggests that this 
pathway is not confined to higher organisms [93]. The 
4.5 S RNA of E. coli (thefts gene product) has sequence 
homology to the 7 SL RNA of SRP, theffh gene product, 
Fth, is homologous to SRP54, and theflsY gene product 
is homologous to SRct [16, 120, 129]. While evidence 
indicates that the 4.5 S RNA of E. coli is involved in 
general protein synthesis [23, 53], it may also function in 
protein translocation as it associates with Fth into a ri- 
bonucleoprotein complex that interacts with the signal 
sequence part of nascent chains [95] and binds tightly to 
FtsY in a GTP-dependent manner [101]. The SRP se- 
cretion pathway in Eukaryotes utilizes a translational r- 
rest mechanism, but there is no evidence that this occurs 
in E. coli [53]. The Fth protein, however, can substitute 
for SRP54 in a mixed reconstitution with eukaryotic SRP 
components with respect o the particle formation and 
the translation arrest activity [16]. This chimeric particle 
does not interact with the eukaryotic SRP receptor and 
fails to facilitate translocation activity. In vivo depletion 
or overexpression f 4.5 S RNA causes retardation ofBla 
export but not of other exported proteins [53, 119, 128]. 
Interestingly, Bla shows the slowest post-translational 
export kinetics in E. coli, and does not require SecB but 
uses GroEL [84, 85]. Depletion of Fth [114] or depletion 
or overexpression [94] of FtsY causes growth arrest and 
export retardation of several precursor proteins. In vitro, 
FtsY depletion retards the export of Bla approximately 
twofold [94]. FtsY localizes at or near to the cytoplas- 
mic membrane in E. coli [94], suggesting that it may 
interact with other membrane components ( ee below), 
or perhaps an as yet unidentified homologue of the mam- 
malian SR[3. 
Although the precise relationship between the SRP 
pathway and the Sec pathway is not clear at present [13, 
93], certain parallels exist between the bacterial and 
mammalian systems. The SRP pathway may function as 
an extension to the Sec pathway. For instance, it may 
fulfill an early chaperone role, and transfer nascent 
chains to SecB/SecA. Alternatively, it may permit 
cotranslational translocation at the translocase complex 
or an as yet unidentified translocase complex possibly 
consisting of FtsX, FtsH (see section on integral mem- 
brane components), and/or the FtsE protein that is ho- 
mologous to the ATP-binding component of the ABC 
(ATP binding cassette) family of transport systems. In 
analogy with the mammalian SEC61p [51], SecY/E may 
bind ribosomes. This may be especially relevant to the 
membrane insertion of proteins. Due to their hydropho- 
bicity these proteins are difficult to stabilize in the cyto- 
sol in a soluble form. There is, however, no clear con- 
sensus as to whether polytopic membrane proteins use 
the Sec pathway for membrane integration or not [ 1, 64]. 
Some membrane proteins eem to require SecY and not 
SecA [146], opening the exciting possibility that SecA 
can be bypassed and that the SecY/E protein complex 
can be directly accessed. The SRP and chaperone path- 
ways may thus coexist for general protein export, con- 
verge at the SecY/E protein complex and/or differ in the 
timing of nascent chain association. 
SecA Is THE DISSOCIABLE, ATPase  SUBUNIT OF 
THE TRANSLOCASE 
SecA is a dissociable subunit of the translocase [162, 
164]. Structural analysis [M. Spiering, A.J.M. Driessen, 
E. Boekema, unpublished] of the SecA protein bound to 
the lipid surface indicates that SecA exists as a (homo-)- 
dimer [3]. The protein retains its dimeric structure dur- 
ing translocation, and studies on the "half-of-sites" ac- 
tivity demonstrates that the dimer is the catalytic unit 
[42]. SecA functions as a receptor for the SecB- 
precursor protein complex [56] and couples ATP hydro- 
lysis to the translocation of precursor proteins across the 
membrane [89, 111]. Many of the functions of SecA are 
presently revealed and these are discussed in this section. 
SecA Is a Precursor Protein-stimulated ATPase with 
Two ATP-binding Domains 
SecA harbors a low endogenous ATPase activity that is 
enhanced up to 100-fold when it interacts with precursor 
proteins, the SecY/E protein complex, and anionic phos- 
pholipids [25, 89, 90]. This activated ATPase activity, 
i.e., "translocation ATPase," is needed for in vitro trans- 
location. Azide is a specific inhibitor of the translocation 
ATPase [110], and blocks both in vitro and in vivo trans- 
location. Many of the azide-resistant mutants of E. coli 
[110] and Bacillus subtilis [R. Freudl, personal commu- 
nication] map in the secA gene. SecA is the only ATPase 
that is needed and sufficient o drive in vitro protein 
translocation [89]. The protein can be photoinactivated 
by the nucleotide-analogue 8-azido-ATP that binds to 
two distinct sites on the SecA protein. Inner membranes 
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Fig. 2. Domain structure of the SecA protein. 
Regions that are possibly involved in membrane 
and precursor protein interactions are shown. 
Hatched areas indicate clusters of 
dominant-negative mutations [66], and the 
triangles indicate point mutations that render the 
protein temperature-sensitive (Ts),azide-resistant 
(Azicle ~) or allow the translocation of precursor 
proteins with defective signal sequences (Prl). A1 
and B1, and A2 and B2 represent the regions with 
similarity to the Walker A and B motifs as found 
in NTP-binding proteins. 
treated with 8-azido-ATP are inactive for translocation, 
and activity can be restored by adding back fresh SecA 
[89]. The two nucleotide-binding sites on SecA have 
been localized by cross-linking studies and analyzed by 
site-directed mutagenesis [100, 105, 146]. The amino- 
terminus harbors the high-affinity nucleotide-binding 
site (Ko, AO P 0.13 ~tM) with similarity to the typical 
Walker A and B sequence motifs found in many ATP- 
binding proteins (Fig. 2; A1 and B1) [156]. Mutations in 
the critical residues of both domains have a strong effect 
on translocation and SecA translocation ATPase activity 
[74, 105, 164]. The region in SecA corresponding tothe 
B-domain is rather atypical as it shows an adjacent du- 
plication of this motif, i.e. (i) one with homology to the 
DEAD box found in RNA-binding proteins, such as he- 
licases [77], and (ii) one that aligns with the B domain of 
the ATP-binding site of ABC proteins. The latter is well 
conserved among SecA proteins. Both domains, how- 
ever, are important for SecA function and both are in- 
volved in Mg 2§ and ATP hydrolysis [165; J. van der 
Wolk, M. Klose, R. Freudl, A.J.M. Driessen, unpub- 
lished]. The first region may be more specific for the 
ATP-dependent interaction of SecA with its own mes- 
senger RNA which is important for autogenous regula- 
tion of translation [39, 138]. 
The second nucleotide-binding site of SecA is of 
low affinity (Ko, AO P 300-500 ~tM) (Fig. 2; A2 and B2) 
[105]. This region likely has a regulatory function only 
as in vitro, protein translocation can be driven by ATP 
concentrations a low as 1 BM, i.e., about wo orders of 
magnitude lower than the K o for the second domain. 
Many of the dominant-negative mutants in SecA cluster 
around the two ATP-binding motifs that may coopera- 
tively interact [66, 105; J. van der Wolk, A.J.M. Dries- 
sen, unpublished]. 
SecA Forms A Soluble Ternary Complex with 
Precursor Proteins and SecB 
SecA is present in the cell in an approximately 10-fold 
molar excess compared to the other components of the 
translocase. A large portion of the SecA is found in the 
soluble fraction of a cell lysate and some SecA appears 
to be associated with ribosomes [88]. Membrane- 
associated SecA binds SecB with high affinity (K o 150- 
250 nM), and both proteins form an isolable binary com- 
plex in solution [56]. The cellular localization of SecB 
and SecA suggests that hey act early in the protein trans- 
l(oc)ation cascade. Precursor proteins associate with 
SecA in solution, and SecB promotes this interaction by 
binding SecA [56] and preventing the premature r lease 
of precursor protein from SecA [A.J.M. Driessen, un- 
published]. 
The in vitro analysis of the interaction of SecA with 
precursor proteins has provided etailed insight into the 
series of events that finally leads to the initiation of trans- 
location. Several PrlD (prl stands for protein localiza- 
tion) mutations, which suppress export defects caused by 
signal sequence defects, have been found in the secA 
gene [ 18, 133]. Biochemical evidence demonstrates that 
SecA recognizes precursor proteins by binding both the 
signal sequence and mature domain [4, 34, 73, 90]. A 
typical signal sequence consists of a positively charged 
amino-terminus, a central hydrophobic region and a hy- 
drophilic region containing the signal peptidase cleavage 
site [58]. Precursor proteins with a larger number of pos- 
itively charged residues at the amino-terminus bind with 
higher affinity to SecA and translocate more efficiently 
in vitro [73]. Precursor proteins bind to SecA at a posi- 
tion adjacent to the high-affinity ATP-binding site [73]. 
Synthetic signal peptides known to inhibit translocation 
[29] compete with precursor proteins for binding to SecA 
[34]. High levels of ATP antagonize this inhibitory ef- 
fect [34]. Conversely, soluble SecA releases bound ADP 
when it binds precursor proteins [140] and this event 
stimulates ADP-ATP exchange at the SecA protein. 
Synthetic signal peptides have a similar effect, but the 
stimulated ATPase activity is seen only when the signal 
peptide is added in conjunction with the mature domain 
[90]. Soluble SecA binds precursor proteins with higher 
affinity when liganded with ADP, and this binding reac- 
tion provokes a conformational change in the SecA pro- 
tein [140]. ATP hydrolysis drives the release of the pre- 
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cursor protein from SecA [136]. Consistent with this no- 
tion, a mutation in the ATP-binding site of SecA that 
prevents the hydrolysis of ATP converts the protein into 
a state where it binds tightly to precursor proteins [ 164]. 
These observations can be summarized in the fol- 
lowing model: (i) the signal sequence domain of a pre- 
cursor protein binds to SecA, (ii) the SecA-bound ADP is 
discharged, (iii) SecA changes conformation and binds 
the mature region of the precursor protein, (iv) ATP 
binds to SecA, and (v) dislocates the bound signal se- 
quence domain. Finally, (vi) ATP is hydrolyzed, and 
(vii) the mature domain is released from SecA. In solu- 
tion, the turnover of SecA is very slow, allowing cycles 
of precursor protein release and rebinding. SecB pro- 
motes the SecA-bound state of the precursor protein. 
At the membrane, SecA is activated for ATP hydrolysis 
and this drives the release of the precursor protein which 
in turn enters the translocation pathway. 
SecA Insertion into the Membrane May 
Drive Translocation 
About 10-40% of the cellular SecA associates with the 
membrane [26]. SecA-phospholipid interactions are 
thought o be essential for protein translocation. Cells 
depleted of acidic phospholipids are severely blocked in 
protein translocation [155]. These results are obscured 
by the pleiotropic effect of acidic phospholipid depletion 
on the energetic state of the cells [154]. In vitro exper- 
iments established that acidic phospholipids are required 
for membrane binding [59] and translocation ATPase 
activity of SecA [90]. The translocation defect of inner 
membranes or reconstituted proteoliposomes depleted 
from acidic phospholipids can be restored by the rein- 
troduction of these lipids [82]. The amount of SecA as- 
sociated with the cytoplasmic membrane or liposomes 
also increases with increasing acidic phospholipid con- 
tent of the membrane [83]. The interaction of SecA with 
the lipid surface is presumably electrostatic and of poor 
affinity. The unabated interaction of SecA with anionic 
phospholipids renders the protein thermolabile [90]. 
ATP, translocation-competent precursor proteins [90], 
and the SecY/E protein complex [25] stabilize the lipid- 
bound SecA. This process is termed "SecA lipid- 
ATPase," and is suppressed by divalent cations uch as 
Mg 2§ Purified SecA penetrates efficiently into a lipid 
monolayer containing acidic phospholipids [20]. ATP 
hydrolysis prevents this insertion and favors a soluble 
state of the SecA protein, whereas it does not prevent 
membrane insertion of a SecA ATPase mutant [164]. 
In the ADP-bound state, SecA associates with the mem- 
brane surface, while in the presence of nonhydrolyzable 
ATP analogues the inserted state dominates. At the lipid 
surface, SecA unfolds [122] into an inactive, aggregated 
state [A.J.M. Driessen, unpublished]. 
How do these findings on the insertion of SecA into 
artificial membranes relate to the in vivo function of 
SecA? With liposomes, SecA will only bind with low 
affinity to the membrane [59]. The presence of the in- 
tegral components ofthe translocase allows high-affinity 
binding (K o 40 nM) [56]. SecA bound to these high- 
affinity sites exposes domains to lipid [122]. In the pres- 
ence of a nonhydrolyzable ATP analogue SecA can tem- 
porally span the entire membrane exposing a region to 
the periplasmic face of the membrane [44a]. In sum- 
mary, these data suggest that SecA may undergo nucle- 
otide-modulated cycles of membrane insertion and ex- 
clusion [20]. Coinsertion of the bound precursor protein 
with SecA may allow the translocation f small polypep- 
tide domains across the membrane as outlined in Fig. 3. 
SecA is only slowly released from the high-affinity bind- 
ing sites, but in the presence of ATP it is rapidly replaced 
by free SecA [164]. This process is blocked in a SecA 
ATPase mutant [164], further supporting the notion that 
the membrane-associated s ate of SecA is modulated by 
its interaction with nucleotides. SecA may act in trans 
such that once it has completed the initiation of translo- 
cation, it is replaced at the translocation site by cytosolic 
SecA loaded with a newly synthesized precursor protein. 
An Evolutionary Conserved Complex of Membrane 
Proteins That Constitutes the Transmembrane 
Translocation Pathway 
Most of the genes identified as components required for 
protein export code for integral membrane proteins 
[132]. The membrane-integrated domain of the translo- 
case consists of three polypeptides, i.e., SecY, SecE and 
a protein termed "band 1" (or SecG, see below) [25]. 
SecY and SecE are essentially for the viability of E. coli, 
and are needed for in vitro and in vivo protein translo- 
cation [63, 162]. SecY is a polytopic membrane protein 
predicted to span the membrane ten times [63]. SecE 
contains three transmembrane s gments (TMS) [134]. 
Only the carboxyl-terminal TMS plus attached se- 
quences uffice for activity [133]. In many other Bacte- 
ria, SecE harbors only a single TMS showing homology 
to the carboxyl-terminal region of the E. coli SecE [57, 
106]. Band 1 is a protein that copurifies and coimmu- 
noprecipitates with SecY and SecE as a three-component 
complex [25] that is labile at ambient temperature [24]. 
This complex (SecY/E complex) has been purified to 
homogeneity by virtue of its ability to support SecA 
translocation ATPase [25, 43]. In reconstituted form, it 
mediates multiple turnovers of SecA-dependent precur- 
sor-protein translocation and is as active for protein 
translocation asinner membrane vesicles [15, 25]. SecY 
and SecE can also be isolated separately from overpro- 
ducing cells and can then be reconstituted together to 
yield active proteoliposomes [2, 108, 151]. The activity 
of these proteoliposomes, however, is low and a new 


















Fig. 3. Sewing model for the intermediate stages of protein translocation. SecA with bound ADP associates with the membrane surface and binds 
with high affinity to a polypeptide omain of a membrane-spanning translocation intermediate that is trapped by the SecY/E/G complex (step 1). 
This binding event promotes the translocation f a small polypeptide omain of the intermediate (step 2), and the interaction of SecA with the 
precursor protein and the SecY/E/G complex activates it for ADP-ATP exchange. Binding of ATP facilitates the insertion of SecA into the 
membrane orSecY/E/G complex, and allows further translocation f a small polypeptide omain of the intermediate through coinsertion (step 3). 
Subsequent hydrolysis of ATP by SecA drives the release of the bound intermediate and promotes the exclusion of SecA from the membrane-bound 
state (step 4). At that stage, translocation is further driven by Ap, or SecA can rebind the translocation intermediate to drive further limited 
translocation (repeat of steps 1--4). SecA with bound ADP is surface localized and can be replaced by cytosolic SecA. 
membrane protein, P12, has been identified that dramat- 
ically enhances translocation [109]. P12 is a small mem- 
brane protein predicted to span the membrane twice. 
Disruption of the p12 gene confers cold sensitivity to 
protein export [109a]. P12 and band 1 share many phys- 
icochemical properties in common. Recent evidence 
shows that both proteins are identical and form the third 
component ermed SecG [39a]. The three-component 
organization of the translocase appears to be conserved 
in Bacteria, Archaea and Eukarya. Recently, the mam- 
malian SEC61p complex of the ER has been purified 
and functionally reconstituted into proteoliposomes [52]. 
This complex also consists of three polypeptides, i.e., 
SEC61cr and y (also known as SSS1) which are homol- 
ogous to SecY and SecE [51, 57], and SEC61~ which 
may be the functional homologue of P12 or "band 1." 
The conserved nature of the molecular organization of 
the translocase complex strongly suggests that the basic 
mechanism of protein translocation i Bacteria, Archaea 
and the ER of Eukaryotes is similar. 
Biochemical evidence indicates that SecE deter- 
mines the stable existence of SecY in the cell [97, 150]. 
In wild-type cells, the newly synthesized SecY immedi- 
ately associates with SecE and "band 1" to form a com- 
plex that does not dissociate during translocation [68a]. 
This contrasts with genetic data arguing that SecE and 
SecY are dissociatable subunits [18]. Mutations in SecY 
that affect the association between SecY and SecE are 
clustered in the second cytosolic loop (C4 domain) of 
SecY. The presence ofprl mutations in the secY (prlA), 
and secE (priG) genes suggests that SecY and SecE in- 
teract with the signal sequence domain. Most condi- 
tional lethal mutations in secY and secE are cold sensi- 
tive. Temperature-sensitive mutations are known only 
for secA and secY. Pogliano and Beckwith [117] pro- 
posed that the protein translocation pathway includes 
some intrinsic cold-sensitive steps, and a lowering of the 
activity in a step following the cold-sensitive step invari- 
ably leads to the cold-sensitive xport phenotypes. A
potential cold-sensitive step is the insertion of the signal 
sequence into the membrane before it may associate with 
the SecY/E complex. 
Several factors have been identified that stabilize 
overexpressed SecY and suppress the dominant negative 
phenotype of secy-dl, a gene that codes for an inactive 
SecY protein with an internal deletion [K. lto, personal 
communication]. When expressed from a multicopy 
plasmid, Secy-dl  sequesters SecE and competes with 
wild-type SecY for the formation of functional translo- 
cation complexes [139]. One of these suppressors is 
Ydr, a small hydrophilic protein that is able to partially 
stabilize the wild-type SecY. The function of Ydr is un- 
clear as the disruption of its gene has no effect on protein 
translocation. Ydr does not functionally replace SecE, 
but may only mimic SecE by stabilizing SecY. The 
amino-terminus of Ydr bears homology to the conserved 
cytosolic region of SecE [T. Shimoike, A.J.M. Driessen, 
K. Ito, unpublished]. Likewise, expression of yajC, a 
gene upstream in an operon that contains the secD and 
secF genes [118], from a high-copy plasmid stabilizes 
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overexpressed SecY [K. Ito, personal communication]. 
yajC codes for a small membrane protein, but there is no 
evidence that it represents another sec gene [118]. 
It has been suggested that SecY is not required for 
translocation [160]. The SecY protein is not soluble in 
the detergent cholate, and this property can be used to 
obtain reconstituted proteoliposomes depleted from 
SecY. These proteoliposomes contain an assembly of 
unspecified membrane proteins and translocate a car- 
boxyl-truncated form of pre-MBP in a SecB- and SecA- 
dependent manner [159, 160]. This contrasts with the 
overwhelming enetic and biochemical data that SecY 
requires for translocation [see reviews 63, 132, 162] and 
are conserved in nature. The discrepancy between these 
observations i  difficult to explain, but it does not seem 
to be appropriate oblame it on the methodology used to 
assay translocation without a critical assessment of the 
generated data [159] realizing that it concerns compari- 
son of a crude [158] with a well-defined system [2, 15, 
24, 25, 41, 108, 109, 151]. The folding properties of the 
truncated pre-MBP may render this protein less SecY 
dependent than native substrates like pre-MBP, pro- 
OmpA and pre-OmpF which translocate in the purified 
system. In this respect, it is important to emphasize that 
the translocase was purified based on its ability to acti- 
vate SecA for precursor protein-stimulated ATPase ac- 
tivity [25], and that the purified complex contained com- 
ponents that were previously identified through exten- 
sive genetic screenings [17, 132]. 
The exact function of the membrane-embedded o- 
main of the translocase is unknown. So far, only indi- 
rect evidence indicates that SecA may bind at a site near 
to SecY [45]. Antibodies directed against SecY interfere 
with high-affinity binding of SecA to membranes [56] 
and prevent ranslocation [158]. SecA protects SecY 
against proteolysis by externally added proteinase [56]. 
The SecY/E complex may act as a transporter or pore, 
allowing precursor proteins to traverse the membrane, 
either through its center or along its surface. Trans- 
location intermediates, i.e., precursor proteins that are 
trapped in an intermediate stage of translocation, can be 
specifically photocross-linked to the SecA and SecY pro- 
teins [68]. Neither SecE nor band 1 are identified with 
this technique, while phospholipids are nearly com- 
pletely protected from cross-linking. SecA and SecY 
thus physically interact with the translocating polypep- 
tide chain. In this respect, the mammalian SEC61~ has 
been specifically cross-linked to translocation i termedi- 
ates that differed in the position of the photoactivatable 
cross-linker such that a complete turn of a putative t~-he- 
lical segment of the intermediate was covered [105a]. 
These data strongly suggest that the translocation i ter- 
mediate is surrounded by a proteinaceous wall formed by 
the SEC61p. 
Does the SecY/E complex function as a protein- 
conducting pore? Black lipid membrane studies with 
everted inner membrane vesicles or spheroplasts of E. 
coli show that the addition of a synthetic signal peptide 
provokes alarge increase in the conductivity of the mem- 
brane [143]. These observations have been taken to sug- 
gest that precursor proteins are translocated through a 
proteinaceous aqueous pore that opens upon binding of 
the signal sequence domain. There is no evidence for the 
involvement ofSec proteins in this process, nor is it clear 
whether these channels also translocate proteins. Further- 
more, the fact that this phenomenon depends on a non- 
physiological polarity of the transmembrane potential 
(A~), i.e., negative on the trans-side instead of positive 
[143], is unsatisfactorily discussed. It will be of interest 
to determine if this signal peptide-dependent io  channel 
is also present in SecY-depleted membrane vesicles 
[160]. E. coli inner membrane vesicles show an en- 
hanced halide permeability when conditions are used that 
result in the accumulation of translocation i termediates 
[137]. Similar observations have been made for the pro- 
ton permeability of membrane vesicles containing ele- 
vated levels of SecY and SecE protein [72]. This in- 
creased halide permeability is also observed with lipo- 
somes reconstituted with the SecY/E complex, and is 
suppressed by the SecA protein (i.e., like a cork on a 
bottle) [A.J.M. Driessen, unpublished]. The ion channel 
opens again when a translocation-intermediate is trapped 
in the translocase. Channel formation is not triggered by 
synthetic signal peptides. Rather, they prevent ranslo- 
cation at an early stage by competing with precursor 
proteins for SecA binding. Similar electrophysiological 
measurements have been carried out with microsomes 
derived from the mammalian ER [142]. When fused to a 
black lipid bilayer, large ion channels appear when the 
polysomes are dissociated from the nascent chains and 
the membrane surface. The permeability barrier between 
the cytoplasm and the ER lumen is thought o be main- 
tained by a tight junction between the ribosome and the 
translocator, i.e., the SEC61p complex. Current evi- 
dence, both in the bacterial and eukaryotic systems, fa- 
vors the idea that proteins are translocated across the 
membrane along a proteinaceous surface [67]. 
Is the SecY/E protein complex apassive component 
or truly involved in catalysis for instance, in energy 
transduction, protein unfolding and/or ecognition. Pro- 
teins bearing an internal nonpolypeptide stretch do trans- 
locate, indicating that peptide-backbone recognition is 
not required throughout the translocation reaction [70]. 
The SecY/E complex, however, must be able to recog- 
nize stop-transfer sequences (or TMS) in translocating 
membrane proteins to release these proteins into the cy- 
toplasmic membrane. The reconstituted SEC61p com- 
plex mediates the insertion of class I and class II mem- 
brane proteins [52]. There are no data available on the 
bacterial system in this respect; however, additional 
components may be required for the assembly of these 
proteins. One possible candidate is FtsH, a membrane- 
bound ATPase that belongs to a family of proteins that 
include the Eukaryotic counterparts of the ER/golgi 
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(SEC18p, NSF), mitochondrion (MSP1, BCS1) and per- 
oxisomes (PASlp). FtsH depletion or mutations in the 
fisH gene interferes with the assembly of membrane pro- 
teins and export of Bla and OmpA [5, 6]. FtsH depletion 
may interfere with the assembly of the translocase sub- 
units, thereby indirectly causing an export defect. FtsH 
may be a component of the translocase that is involved 
in the recognition of stop-transfer signals in translocating 
proteins. It may mediate the opening of the translocase 
subunits to allow the lateral exit of membrane proteins 
into the lipid phase. 
ANIONIC PHOSPHOLIPIDS ARE NEEDED EARLY 
IN TRANSLOCATION 
Along with their role in targeting the precursor protein to 
SecA, positive charges at the amino-terminus of the sig- 
nal sequence may play an additional role in the early 
stages of translocation. The positively charged amino- 
terminus of the signal sequence of precursor proteins 
may interact electrostatically with anionic phospholipids 
in the membrane, possibly favoring the insertion of the 
hydrophobic core into the bilayer via the formation of a 
loop with the mature amino-terminus [58, 62]. Much 
indirect evidence has been gathered to support his view. 
A tentative correlation exists between the ability of syn- 
thetic signal peptides to insert into model membranes 
and to act as efficient argeting signals in protein trans- 
location [22]. The total hydrophobicity of the core re- 
gion is an important determinant for signal sequence 
function [60]. For instance, the requirement for a posi- 
tive charge at the amino-terminus can be compensated 
for by a longer central hydrophobic stretch [61]. Under 
those conditions, translocation becomes less dependent 
on anionic phospholipids [115], suggesting that precur- 
sor proteins with a "classic" signal sequence indeed 
encounter the anionic phospholipids at an early stage of 
the translocation reaction. Anionic lipids are also re- 
quired for the initial Sec-independent i sertion of M13 
procoat [81], possibly reflecting a primordial route of 
translocation. In subsequent s eps, the signal sequence 
may associate with the SecY/E complex. It is not known 
if lipids are functionally involved in the later stages of 
translocation. Signal sequence-phospholipid interactions 
are not considered in models describing the translocation 
of proteins into the mammalian ER. Rather, experimen- 
tal evidence in the yeast ER indicates that during an early 
stage in translocation, the signal sequence of nascent 
chains is in close contact with SEC61p [107, 131], while 
recent data with dog pancreas microsomes suggest that 
the signal sequence passes through an aqueous compart- 
ment in the membrane during translocation possibly at 
the SEC61p [33]. 
A Model for the Catalytic Cycle of the Translocase 
Translocation of proteins through the Sec system has 
been shown to be dependent on two different sources of 
free energy: ATP hydrolysis and the protonmotive force, 
Ap (Ap is composed of a transmembrane el ctrical po- 
tential, A~, and the pH difference across the membrane, 
ApH) [27, 28, 37, 40, 44, 49, 167, 168]. This dual energy 
requirement may be unique for bacterial protein translo- 
cation. ATP (or GTP) is required for most protein trans- 
location processes that occur across biological mem- 
branes. Generally, NTP hydrolysis drives the release of 
precursor proteins from their association with molecular 
chaperones. Protein import into mitochondria requires 
A~ only for the initial electrophoretic movement of the 
signal sequence across the inner membrane [112]. Some 
proteins imported into the thylakoid of the chloroplast 
specifically utilize ApH for translocation and membrane 
insertion [30], while import of proteins into the chloro- 
plast or the ER appears to be totally independent of a Ap 
[127]. Detailed in vitro studies with the bacterial system 
have led to the definition of a catalytic ycle of the 
translocase. This model proposes that translocation pro- 
ceeds in a stepwise manner [136], and is discussed in the 
following paragraphs. 
ATP HYDROLYSIS BY SecA Is NEEDED TO 
INITIATE TRANSLOCATION 
At the membrane, the targeting cascade recommences 
with the binding of the SecA subunit to the integral com- 
ponents of the translocase [56]. Several scenarios can be 
envisioned based on the possible existence of a lipid 
surface-bound, freely diffusible intermediate composed 
of the ternary complex of SecA, SecB and the precursor 
protein [56]. Such a complex may laterally diffuse to the 
translocation site, and eventually replace a previously 
bound SecA subunit. So far, there is no evidence that a 
lipid-bound ternary complex is a true intermediate in the 
targeting cascade. This complex may as well directly 
associate with the SecY/E protein [56]. SecA uses the 
energy of ATP binding to insert into the membrane [20] 
and to release the signal sequence domain of the bound 
precursor protein [136]. The signal sequence domain 
may then interact with anionic phospholipids ( ee previ- 
ous section), adopt a loop-like structure with the mature 
amino-terminal region and insert into the membrane or 
the translocation channel. In vitro studies have demon- 
strated that in the presence of non-hydrolyzable ATP 
analogues, precursor proteins are translocated across the 
membrane to the extent hat the signal sequence can be 
cleaved by signal peptidase [136]. Since the active site 
of signal peptidase is exposed to the periplasmic face of 
the inner membrane, about 40-45 residues must have 
been translocated. The length of the hydrophobic core of 
the signal sequence domain (10-15 amino acid residues) 
varies considerably among precursor proteins and is too 
short to span the entire membrane in o~-helical confor- 
mation [58]. Penetration of SecA into the lipid bilayer 
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may serve to shorten the distance for the amino-terminus 
to get across, or facilitate astable interaction of the signal 
sequence with "putative" binding sites on the SecY/E 
complex. Initial anchoring at the SecY/E complex and 
subsequent binding of the mature domain may prevent 
precursor proteins from diffusing away from the trans- 
location site. The interaction between SecA and the 
SecY/E protein complex activates SecA for ATP hydro- 
lysis. This process drives the release of the precursor 
protein from SecA and may promote xlcusion of SecA 
from the membrane-inserted state [20, 164]. These se- 
res of events ensure that he precursor protein is released 
by SecA at the translocation site, and preclude an unpro- 
ductive insertion of the precursor protein into the lipid 
bilayer as observed in model systems [136]. It is not 
clear at what stage SecB is released from the precursor 
protein. In vitro, SecB is already redundant when the 
ternary complex has docked at the membrane transloca- 
tion site [56]. 
Ap DRIVES TRANSLOCATION IN THE ABSENCE OF SecA 
Once translocation has been initiated at the expense of 
ATP, further translocation may proceed stepwise through 
a series of transmembrane i termediates, each with dis- 
tinct energy requirements. This process can be separated 
in SecA-dependent steps (which requires ATP), SecA- 
independent steps (driven by Ap), and steps most likely 
driven by interaction of the preprotein domain with the 
translocase and/or phospholipids [48, 136, 148]. In the 
intermediate stages of translocation, SecA can rebind a 
translocation i termediate, insert into the membrane and 
through coinsertion drive the forward membrane trans- 
location of a 4 kD polypeptide stretch (Fig. 3) [136]. 
Binding of ATP may then promote further coinsertion of 
SecA with bound precursor protein into the membrane, 
allowing the limited translocation of another 4 kD 
stretch. Subsequent ATP hydrolysis elicits the release of 
the protein from its association with SecA and may fa- 
cilitate membrane deinsertion of SecA. Multiple cycles 
of these SecA-dependent translocation steps ultimately 
lead to the complete translocation of the polypeptide 
chain [136]. This process is very inefficient and slow 
and requires the hydrolysis of numerous ATP molecules 
[40]. Truncated pro-OmpA derivatives require less ATP 
for translocation [14]. In vivo, it seems more likely that 
Ap drives further translocation once SecA has released 
the precursor protein to the SecY/E complex. Ap permits 
rapid and efficient ranslocation of intermediates pro- 
vided that they are not associated with SecA [40, 136]. 
Ap-driven translocation is completely blocked when the 
precursor protein associates tightly with SecA, i.e., with 
nonhydrolyzable ATP analogues [136] or when SecA is 
unable to hydrolyze ATP through amutation in the ATP- 
binding site [164]. Excess SecA suppresses the Ap- 
dependency ofprecursor-protein translocation [166] as it 
favors rapid rebinding of released precursor proteins. 
The observation that translocation is more dependent on 
Ap when SecA is limiting is consistent with this expla- 
nation [166]. The intermediate stages of translocation 
are readily reversible and SecA-mediated ATP hydroly- 
sis is not strictly coupled to net precursor protein move- 
ment along the translocation path [136]. Futile cycles of 
ATP hydrolysis occur when translocation is prevented by 
a stable tertiary structure in the precursor protein [136, 
149] or when a Ap of reversed polarity is imposed [40]. 
In the absence of SecA association, "backward" trans- 
location of intermediates can take place [136] that is 
prevented by Ap [40]. These futile cycles are presum- 
ably the cause of poor coupling between translocation 
and ATP hydrolysis found in vitro. Phenomenologi- 
cally, Ap increases the coupling ratio between ATP hy- 
drolysis and precursor protein translocation [40]. Mech- 
anistically, these processes are completely distinct [136]. 
In vivo, the main catalytic role of SecA may be to 
initiate translocation atthe expense of ATP and to donate 
the precursor protein to the SecY/E protein complex dur- 
ing a transient interaction to allow further Ap-driven 
translocation [41, 136]. SecA may then be needed only 
occasionally at later stages of the translocation reaction 
to permit ransit of stable-folded tertiary structures in the 
polypeptide chain [147, 149]. Alternatively, SecA may 
drive the complete translocation reaction in a stepwise 
fashion, while Ap prevents backward translocation and 
thus ensures unidirectionality (see section on Ap). 
SecD AND SecF FACILITATE TRANSLOCATION AT A 
LATE STAGE 
SecD and SecF are both membrane proteins that were 
identified by cold-sensitive mutations that cause the ac- 
cumulation of precursors of exported proteins [46]. The 
number of SecD and SecF molecules in the cell is ap- 
proximately 1/lO the number of SecY and SecE molecules 
[99, 134], although there is uncertainty on the precise 
abundance of SecD [99, 118]. None of the prl mutations 
mapped in the secD and SecF genes, and it has been 
suggested that they are not involved in signal sequence 
recognition [19, 132]. Both proteins have large periplas- 
mic domains positioned between the first two of six TMS 
[116, 117], and are not required for the biochemically 
reconstituted translocation reaction [25]. secD and secF 
null mutants are viable only at high temperatures and 
show a severe, cold-sensitive export defect [118]. Over- 
expression of SecD and SecF improves the export of 
proteins with defective signal sequences [118]. Genetic 
evidence indicates that SecD and SecF are dissociable 
subunits of the translocase at a late stage of translocation 
[19]. They are not associated, however, with the isolable 
SecY/E complex. Protein export in spheroplasts i  in- 
A.J.M. Driessen: Bacterial Protein Export 155 
hibited when incubated with an antibody against SecD 
[98] and the data suggest hat SecD is needed or im- 
proves the efficiency of the release of the proteins in the 
periplasm. SecD and SecF are not required for clearing 
of the precursor protein from the translocation site per se, 
since the reconstituted translocase mediates multiple 
rounds of translocation i their absence [15]. Depletion 
of SecD and SecF severely affects the ability of cells to 
maintain Ap [9]. This may be the reason for the trans- 
location defect in secD and secF mutants. In vitro stud- 
ies demonstrate hat SecD and SecF are not needed for 
ATP-dependent translocation, but that they kinetically 
affect the Ap-dependent portion of the translocation re- 
action [9]. SecD and SecF, however, are not essential for 
coupling of Ap to translocation as shown with the recon- 
stituted system [25, 40]. Why are secD and secF null 
mutants leaky for protons? Since translocation is slow in 
these mutant strains, leakiness could possibly arise from 
translocase units stuffed with translocation i termediates 
(see section on SecY/E protein). These units would 
present a major energy sink in cells causing the dissipa- 
tion of Ap. By rapidly clearing the translocase, SecD 
and SecF may prevent the occurrence of such undesired 
ion fluxes. In many aspects, the in vivo dissipation of Ap 
resembles the effect of the depletion of SecD and SecF. 
In the presence of an uncoupler, a membrane-bound pro- 
cessed intermediate of pre-MBP accumulates at the 
periplasmic side of the inner membrane [47]. Ap may 
thus be involved in the release of MBP, and possibly also 
other precursor proteins. Precursor proteins are affected 
in different ways in their translocation i SecD and SecF 
mutant strains. This effect may be related to their Ap 
dependency of translocation. 
Several other factors have been found that affect 
folding and/or elease of exported proteins on the exter- 
nal face of the membrane. Signal peptidases I and II are 
needed to remove the signal peptide domain of precursor 
proteins and prelipoproteins [35]. The periplasm of E. 
coli contains at least two functional homologues of the 
eukaryotic protein disulfide isomerases (PDI). DsbA [12, 
69, 163] and DsbC [104, 135] are periplasmic proteins 
believed to be involved in the oxidation of cysteine res- 
idues and disulfide-bond rearrangements in exported 
proteins. DsbA, whose molecular structure has recently 
been solved [96], is a periplasmic protein that acts in 
concert with the membrane-bound DsbB [11]. It has 
been suggested that DsbB specifically reoxidizes DsbA 
via the electron transfer chain, thus enabling it to recycle 
[11,103]. In the absence of DsbA, these proteins remain 
bound at the periplasmic membrane surface in a reduced 
and unfolded state. Homologues of the SecA, SecE and 
SecY polypeptides have been found in a wide variety of 
Bacteria. As yet unique to Gram-positive Bacteria are 
PrsA and PrtM, both small, membrane-anchored, li- 
poproteins that are involved in the maturation of ex- 
ported proteins in B. subtUis and Lactococcus lactis, re- 
spectively [54, 65, 76]. These proteins may function as 
folding factors that act in concert with the Sec system. 
What Forces Drive Proteins across the Membrane? 
Do PROTEINS TRANSLOCATE BY DIFFUSION AND 
BROWNIAN MORON? 
What forces drive proteins across the membrane, and 
does active unfolding take place? It is generally believed 
that precursor proteins need to be in a so-called "loosely 
folded state" in order to be translocated [125]. This term 
is not well defined as it does not indicate the degree of 
folding. Translocation-competent precursor proteins 
show significant elements of final secondary and tertiary 
structure [21, 86]. This translocation-competent co for- 
mation, however, does not resemble the "molten- 
globular," a conformation found in early intermediates 
in the protein-folding pathway which exhibits a native- 
like secondary structure and a collapsed tertiary structure 
lacking any stable elements. The translocase mediates 
the translocation of short segments with tertiary struc- 
ture, i.e., a segment stabilized by a disulfide bridge, pro- 
vided that both energy sources (ATP and Ap) are present 
[147, 149]. Since precursor proteins are translocated as 
partially extended polypeptide chains, the need for un- 
folding is evident. Protein unfolding during transloca- 
tion can be driven by the translocation reaction itself as 
shown by studies with a fusion protein consisting of the 
cytosolic dihydrofolate reductase (Dhfr) linked to the 
carboxyl-terminus of pro-OmpA [8]. This fusion protein 
translocates up to the folded Dhfr-moiety when stabi- 
lized by NADPH and methotrexate. Removal of these 
ligands allows a two-stage translocation reaction, i.e., (i) 
a spontaneous translocation of 20-30 amino acid resi- 
dues concomitant with unfolding of the Dhfr domain, 
and (ii) SecA and ATP-dependent completion of trans- 
location. Transfer of the amino-terminal domain of Dhfr 
to an energetically more favorable position drives the 
unfolding of Dhfr [8]. The same principle may apply to 
the "backward" and "forward" translocation of unsta- 
ble intermediates a , for instance, very late pro-OmpA 
intermediates that translocate to full length when freed 
from a synthetically imposed translocation arrest [136]. 
Earlier intermediates remain at their position in the ab- 
sence of SecA association [136], and require rebinding 
by SecA and cycles of ATP binding and hydrolysis or Ap 
for further translocation. By binding the polypeptide 
chain, SecA may contribute to unfolding since this event 
will restrict he freedom of the bound polypeptide seg- 
ment which may be sufficient o bring about local un- 
folding. Next, SecA drives translocation by "pushing" 
the protein into the channel, and by binding the protein it 
will prevent "backward" translocation. The association 
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of the polypeptide chain with the SecY/E protein com- 
plex (with or without phospholipids) may also contribute 
to unfolding, and allow translocation until a new, ener- 
getically favorable position is attained [8]. In addition, 
protein binding or folding factors and covalent modifi- 
cations of the polypeptide chain in the periplasmic space 
may shift the equilibrium so as to allow further translo- 
cation. In many respects, this model resembles the 
"ratchet model" [144] that proposes that translocation 
through a proteinaceous pore is driven solely by diffu- 
sion and Brownian motion in polypeptides and that the 
proteinaceous components of the translocation apparatus 
and energetic parameters only serve to direct transloca- 
tion. Does the "ratchet" model adequately describe pro- 
tein translocation i the bacterial system? The answer 
must be no if protein translocation is driven by the ATP- 
dependent insertion of SecA into the membrane. More- 
over, unfolded proteins do not translocate spontaneously 
in the bacterial system, rather continuous input of energy 
is required for translocation. 
THE UNRESOLVED MYSTERY OF Ap-DRIVEN TRANSLOCATION 
How does Ap function as a driving force in protein trans- 
location? This major question in the study of protein 
translocation is still a mystery. In vivo and in vitro stud- 
ies have demonstrated that A~ and ApH are equivalent 
forces in translocation [10, 40]. This observation 
strongly argues in favor of an energy-coupling mecha- 
nism in which H§ are directly involved. This is further 
substantiated by the observation that in the marine bac- 
terium Vibrio alginolyticus, protein translocation may be 
coupled to the sodium motive force [152]. There is no 
direct evidence that protein translocation is truly coupled 
to H § movements. The in vivo data utilizing uncouplers 
are complicated by the fact that ApH may affect trans- 
location in a dual manner, i.e., as a driving force and via 
alterations of the cytosolic pH. In vitro studies demon- 
strate that the activity of the translocase is adversely 
affected by a lowering of the pH at the cytosolic face of 
the membrane [44]. Nevertheless, other studies demon- 
strate that ApH acts as a true driving force, implying that 
H+s are involved in the translocation mechanism. One 
possible mechanism would be an H+/polypeptide antiport 
in which protein export is coupled to an inward H + flux 
[41]. Attempts to detect such vectorial W-transfer reac- 
tion have failed thus far. Detection of these fluxes is 
complicated by the appearance of H + leaks that accom- 
pany the in vitro translocation reaction when intermedi- 
ates jam the channel [72, 148; A.J.M. Driessen, unpub- 
lished]. On the other hand, the A~/-driven chase of a 
translocation i termediate ofpro-OmpA is retarded more 
than threefold in deuterium oxide relative to the rate in 
water [44]. Such a kinetic solvent isotope effect is in- 
dicative for critical H+-transfer reactions in a rate- 
limiting step. These H+-transfer reactions, however, do 
not necessarily reflect vectorial H+-translocation steps. 
Studies with translocation intermediates demon- 
strate that Ap drives translocation of large protein do- 
mains without ATP and SecA [136, 148], and small, 
stable-folded domains in the presence of ATP [147, 149]. 
The "putative" translocation channel may adopt a more 
relaxed conformation i the presence of Ap to allow the 
transmembrane translocation of large, folded domains. 
Ap would thus act by widening the size of the translo- 
cation channel to allow "ratcheting" of the translocating 
polypeptide [144]. A reversed Ap would restrict its size 
thereby preventing "forward" translocation. Such a 
model has to invoke a transmembrane H § flux to explain 
the requirement for the total Ap. Binding factors at the 
periplasmic face of the membrane are needed to prevent 
"backward" translocation of the polypeptide chain in 
the absence of SecA. Certain mutations in SecY allow 
the translocation f signal sequenceless proteins, and one 
may argue that this loss of specificity is due to a relax- 
ation of the translocation channel [38]. It is not known if 
these mutations affect the Ap dependency of transloca- 
tion. 
Precursor proteins vary in their requirement for Ap 
for translocation [167]. This may be related to the pres- 
ence or absence of stable-folded tertiary structure le- 
ments [147, 149], the number and affinity of SecA- 
binding sites in the polypepfide chain assuming that there 
is some specificity in these interactions, and the charge 
distribution along the polypeptide chain. Precursor pro- 
teins bearing a mature domain devoid of ionizable resi- 
dues still require Ap for translocation [71]. This implies 
that Ap performs a mechanistic function rather than act- 
ing upon the precursor protein itself as, for instance, 
through protonation/deprotonation or electrophoresis. 
This latter process may be relevant to the initial insertion 
of the signal peptide domain into the membrane [36], and 
several studies indicate that the charge [50] or structure 
[92] of the mature amino-terminal region of pro-OmpA 
is an important factor for the Ap dependency of process- 
ing. Other observations indicate that Ap may modulate 
the activity of SecA by reducing the apparent Km of the 
translocation reaction for ATP thereby allowing Ap- 
driven translocafion at a low ATP concentration [141]. 
This phenomenon has been attributed to an accelerating 
effect of Ap on the rate of ADP release from SecA. An 
indirect modulating role of Ap seems more evident and 
may be found in the ability of Ap to clear the precursor 
protein from the translocation site once it has been re- 
leased by SecA [41]. 
Ap is essential for translocation i  vivo, whereas it is 
only stimulatory in vitro [41]. This apparent discrepancy 
may he the result of multiple phenomena, i.e., (i) the in 
vitro systems used so far to analyze protein translocation 
cannot attain the high levels of Ap found in respiring 
cells, (ii) release of translocated proteins into the 
periplasmic space requires Ap [47], and this step is usu- 
ally not assayed in vitro, (iii) in vitro studies use an 
excess SecA that suppresses the Ap dependency of trans- 
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location [136, 159, 167], and (iv) the collapse of Ap in 
vivo also results in a lowering of the internal pH, which 
adversely affects the activity of the translocase [44]. 
Concluding Remarks 
Now that the complicated process of protein transloca- 
tion as it occurs in the cell can be reconstituted with 
purified components, major research questions can be 
addressed at a more detailed molecular level. These are: 
What is the molecular mechanism by which Ap drives 
translocation? For instance, a biochemical demonstra- 
tion is needed to establish if the channel opening varies 
with Ap. Further comparison of the energetics of bacte- 
rial protein export and the ApH-dependent protein import 
into the thylakoid may reveal salient features of the 
mechanism of energization through Ap. Other important 
questions relate to how membrane proteins integrate and 
assemble into the cytoplasmic membrane, and which 
steps are Sec dependent and independent. The function 
of the small subunits of the translocase needs to be re- 
solved. Do they, for instance, act as valves that control 
the opening and closing of the channel in the lateral 
direction to allow the release of membrane domains. Is 
the folding state of precursor proteins modulated by in- 
teraction with Sec proteins, and which features of the 
mature domain of precursor proteins besides the signal 
sequence domain are recognized by Sec proteins will be 
important to reveal. This information may promote the 
use of bacterial cells as production factories for the se- 
cretion of heterologous proteins that often are only 
poorly secreted. How is the process of the translocation 
of outer membrane proteins across the cytoplasmic mem- 
brane linked to their final assembly into the outer mem- 
brane? In Gram-positive Bacteria it will be of interest to 
determine to what extent he cell wall represents a bot- 
tleneck for the secretion of proteins [145]. Studies are 
needed on the physiological role of protein export in 
differentiation processes, uch as the development of nat- 
ural competence and sporulation in Bacillus species, or 
the possible reversal of protein translocation i E. coli 
upon invasion by the parasite Bdellovibrio crescentus 
[130]. We will learn more about he general features of 
protein export systems by studying the dedicated protein 
export routes in Bacteria involved in the secretion of 
specific proteins across the outer membrane, with or 
without the accumulation of periplasmic intermediates 
[121, 153]. Now that homologues of the major compo- 
nents of the bacterial protein translocation system have 
been found in Archaea and Eukarya, in particular mam- 
mals and yeast, the protein translocation research field 
will converge. Major questions are: What is the role of 
the SRP pathway in E. coli and other Bacteria? How do 
these components interact with the translocase? What is 
the role of FtsH in this process? Does the SRP pathway 
function as an extension or alternative route to the Sec 
pathway? How are these pathways evolved in Archaea? 
In addition to the well-established powerful genetic and 
biochemical tools, biophysical experimentation will add 
further detail to our understanding of the molecular 
mechanism of protein translocation. A stage has been 
reached where detailed information on the structure of 
the translocase is urgently needed. 
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